APA (7th ed.) Citation

B, W., KM, S., D, E., S, Y., G, C., MM, C., . . . CE, F. (2024). Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial. Translational oncology, 43, 101914. https://doi.org/10.1016/j.tranon.2024.101914

Chicago Style (17th ed.) Citation

B, Werner, et al. "Cell-free DNA in Plasma and Ascites as a Biomarker of Bevacizumab Response- a Translational Research Sub-study of the REZOLVE (ANZGOG-1101) Clinical Trial." Translational Oncology 43 (2024): 101914. https://doi.org/10.1016/j.tranon.2024.101914.

MLA (9th ed.) Citation

B, Werner, et al. "Cell-free DNA in Plasma and Ascites as a Biomarker of Bevacizumab Response- a Translational Research Sub-study of the REZOLVE (ANZGOG-1101) Clinical Trial." Translational Oncology, vol. 43, 2024, p. 101914, https://doi.org/10.1016/j.tranon.2024.101914.